Title
Pathogenesis
Causes
Papillary Muscle
Ñ
Papillary muscle dysfunction
Ñ
Rupture of the papillary muscle:
Myomalacia cordis following myocardial infarction
Chordae Tendinae
Ñ
Rupture of the chordae tendinae:
Infective endocarditis
Mitral valve prolapse
Trauma
Rheumatic mitral valve disease
Valve Leaflets
Ñ
Rheumatic carditis
Ñ
Infective endocarditis
Ñ
Valvotomy
Ñ
Floppy mitral valves
Ñ
Degenerative changes
Ñ
Prosthetic valve dysfunction
Valve Ring
Ñ
Left ventricular dilatation in heart failure
Ñ
Fibrosis
Ñ
Degeneration
Ñ
Paraprosthetic mitral regurgitation
Septum
Ñ
Atrial septal defect:
Ostium primum
Muscle
Ñ
Hypertrophic obstructive cardiomyopathy
Ñ
Endomyocardial fibrosis
Systemic Causes
LMS
Ñ
Marfan’s syndrome
Ñ
Osteogenesis imperfecta
Ñ
Systemic lupus erythematosus
Ñ
Rheumatic fever
IS
Ñ
Ehlers Danlos syndrome
Ñ
Pseudoxanthoma elasticum
Pathophysiology
Ñ
Regurgitation of blood into the left atrium causes left atrial
dilatation
Ñ
Left atrial dilatation leads to atrial fibrillation
Ñ
In long-standing disease the pressure does not rise till late in
the disease process as the left atrium dilates to accommodate the blood
Ñ
In acute regurgitation the atrium does not have time to dilate
Ñ
Left atrial pressure rises quickly
Ñ
When left atrial pressure increases:
·
Pulmonary venous pressure increases and this results in
pulmonary oedema
·
Later pulmonary hypertension occurs
Ñ
As regurgitation of blood from the left ventricle to the left
atrium occurs in systole, the stroke volume must increase to maintain cardiac
output and hence the left ventricle dilates
Clinical Features
History
E&M
Ñ
Fatigue
Ñ
Lethargy
Ñ
Loss of weight:
Cardiac cachexia
CVS
RS
Examination
E&M
CVS
RS
GIT
Investigations
Imaging
Chest X-ray
ECHO
Ñ
Dilated LA (left atrium) and LV
(left ventricle)
Ñ
TOE (transoesophageal
echocardiogram):
Assessment prior to surgery
Cardiac
catheterisation
Ñ
Coexistent coronary artery
disease
Ñ
Coexistent aortic valve disease
Ñ
Prior to surgery
Electrophysiology
ECG
Ñ
LVH and strain
Management
Ñ
Mild disease is managed
conservatively by following the patient with serial echocardiograms
Control
Drugs
Surgery
Ñ
Mitral valve repair or replacement
Indications for
surgery
Ñ
Symptomatic patients:
LVEF
>30%
ESD
<
55mm
Ñ
Symptoms (moderate to severe) despite
medical therapy
Ñ
Asymptomatic patients:
·
LV dysfunction:
ESD
>
45mm
And/or:
LVEF
£
60%
Prevention
Ñ
Endocarditis prophylaxis